Last reviewed · How we verify
Sodium Chloride [3%]
Sodium chloride 3% is a hypertonic saline solution that draws fluid from intracellular and interstitial spaces into the vascular compartment through osmotic gradient.
Sodium chloride 3% is a hypertonic saline solution that draws fluid from intracellular and interstitial spaces into the vascular compartment through osmotic gradient. Used for Hyponatremia (symptomatic or severe), Cerebral edema and increased intracranial pressure, Acute volume expansion in critical care.
At a glance
| Generic name | Sodium Chloride [3%] |
|---|---|
| Also known as | Hypertonic Saline Solution, NaCl |
| Sponsor | Fundacion Clinica Valle del Lili |
| Drug class | Electrolyte solution / Osmotic agent |
| Modality | Small molecule |
| Therapeutic area | Critical Care / Acute Medicine |
| Phase | FDA-approved |
Mechanism of action
The 3% concentration creates an osmotic gradient that pulls water from tissues into the bloodstream, increasing intravascular volume and plasma osmolality. This mechanism is used to treat hyponatremia (low serum sodium) and cerebral edema by reducing intracranial pressure through fluid redistribution. It is also used for volume expansion in acute care settings.
Approved indications
- Hyponatremia (symptomatic or severe)
- Cerebral edema and increased intracranial pressure
- Acute volume expansion in critical care
Common side effects
- Hypernatremia (if overcorrected)
- Phlebitis at infusion site
- Hyperchloremia
- Fluid overload
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Sodium Chloride [3%] CI brief — competitive landscape report
- Sodium Chloride [3%] updates RSS · CI watch RSS
- Fundacion Clinica Valle del Lili portfolio CI